Success Metrics

Clinical Success Rate

100.0%

Based on 6 completed trials

Completion Rate

100%(6/6)

Active Trials

1(14%)

Results Posted

83%(5 trials)

Phase Distribution

Ph phase_3

43%

Ph phase_4

29%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 3Large-scale testing

3(60.0%)

Phase 4Post-market surveillance

2(40.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(6)

Detailed Status

Completed6

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 33 (60.0%)

Phase 42 (40.0%)

Trials by Status

recruiting114%

completed686%

Recent Activity

1 active trials

Showing 5 of 7

recruitingphase_4

Comparing Sarecycline and Doxycycline Effects on the Skin and Gut Bacteria in Acne.

NCT07544251

completed

Clinical Trials (7)

Showing 7 of 7 trials

NCT07544251Phase 4

Comparing Sarecycline and Doxycycline Effects on the Skin and Gut Bacteria in Acne.

Recruiting

NCT04820673

Patient-reported Outcomes for Sarecycline Effectiveness and Safety (PROSES)

Completed

NCT05010538

Sarecycline Truncal Acne Safety and Efficacy Response

Completed

NCT04555525Phase 4

A Pilot Study on the Use of Seysara for Rosacea

Completed

NCT02320149Phase 3

Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne

Completed

NCT02413346Phase 3

A Multi-Center Open-Label Evaluation of the Safety of Sarecycline Tablets in the Treatment of Acne Vulgaris

Completed

NCT02322866Phase 3

Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne

Completed

All 7 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 7